GENE ONLINE|News &
Opinion
Blog

2025-03-31| Trials & Approvals

Breaking New Ground in 2025 with 8 First-in-Class Drugs Close to FDA Approval – Part I

by Denisse Sandoval
Share To
Image source: Maxx-Studio/Shutterstock.com
In 2024, the FDA approved a range of innovative therapies, including gene and cell therapies, targeted biologics, and novel small molecules. Notable approvals included Orchard …

Breaking New Ground in 2025 with 8 First-in-Class Drugs Close to FDA Approval – Part I Read More »

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Parul Butala Appointed President of AMERCO Real Estate Company
2026-07-21
Jonathan Saunders Appointed Executive Creative Director of Kate Spade New York
2026-07-21
WDIV Opens Hybrid Newsroom and Coffee Shop in Downtown Plymouth
2026-07-21
Caesars Palace Launches 1966-Inspired Menus for 60th Anniversary Celebration
2026-07-21
Starco Brands Completes Acquisition of Custom Bakehouse
2026-07-21
FDA Grants Emergency Use Authorization for Seegene Multiplex PCR Assay Detecting Four Viruses
2026-07-21
Urologist Elizabeth Dray Finds No Basis for Linking Homeric Heroism to Modern Testosterone Screening
2026-07-21
READ MORE
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
SEE MORE
Scroll to Top